Corporate News     03-Mar-23
Caplin Steriles receives USFDA approval for Rocuronium Bromide Injection
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories , has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rocuronium Bromide Injection, 10 mg/mL in 5 mL and 10 mL Multi-dose Vials, a generic therapeutic equivalent version of (RLD), ZEMURON Injection, of Organon USA Inc.

Rocuronium Bromide Injection is a neuromuscular blocking agent, indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. According to IQVIATM (IMS Health), Rocuronium Bromide Injection had US sales of approximately $53 million for the 12-month period ending September 2022.

Previous News
  Caplin Point Laboratories allots 12,00 equity shares under ESOS
 ( Market Beat - Reports 27-May-23   16:21 )
  Caplin Point Laboratories to conduct board meeting
 ( Corporate News - 08-May-25   14:47 )
  Caplin Point Laboratories to hold board meeting
 ( Corporate News - 31-Oct-24   12:06 )
  Volumes jump at Caplin Point Laboratories Ltd counter
 ( Hot Pursuit - 01-Oct-24   14:30 )
  Caplin Point Laboratories fixes record date for dividend
 ( Market Beat - Reports 27-May-23   16:20 )
  Gland Pharma Ltd leads gainers in 'A' group
 ( Hot Pursuit - 08-Aug-23   12:00 )
  Caplin Point Laboratories consolidated net profit rises 30.06% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   15:15 )
  Caplin Point Laboratories consolidated net profit rises 19.08% in the March 2024 quarter
 ( Results - Announcements 16-May-24   15:05 )
  Board of Caplin Point Laboratories recommends Interim Dividend
 ( Corporate News - 16-May-24   14:24 )
  Caplin Steriles receives USFDA approval for Thiamine Hydrochloride Injection
 ( Corporate News - 08-Mar-23   11:54 )
  Caplin Point gains after arm gets USFDA final nod for thiamine deficiency drug
 ( Hot Pursuit - 08-Mar-23   11:16 )
Other Stories
  Vintage Coffee And Beverages to hold board meeting
  01-Jul-25   18:44
  Hind Rectifiers to convene AGM
  01-Jul-25   18:44
  Lupin carves-out its LupinLife Consumer Healthcare
  01-Jul-25   18:39
  Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Gel
  01-Jul-25   18:37
  LTIMindtree introduced its GCC-as-a-Service
  01-Jul-25   18:34
  Hyundai Motor India sells 60,924 units in June'25
  01-Jul-25   18:33
  Maruti Suzuki India records 6.26% decline in June sales
  01-Jul-25   18:30
  RateGain forges strategic partnership with Cloudbeds
  01-Jul-25   15:24
  Aurionpro Solutions announces strategic win with a leading UK-based financial institution
  01-Jul-25   15:17
  Tata Motors Q1 sales decline 8% to 2.10 lakh units
  01-Jul-25   15:08
Back Top